APA (7th ed.) Citation

Jarosz-Griffiths, H. H., Gillgrass, L., Caley, L. R., Spoletini, G., Clifton, I. J., Etherington, C., . . . Peckham, D. (2024). Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. PLoS ONE, 19(5), 1. https://doi.org/10.1371/journal.pone.0304555

Chicago Style (17th ed.) Citation

Jarosz-Griffiths, Heledd H., Lindsey Gillgrass, Laura R. Caley, Giulia Spoletini, Ian J. Clifton, Christine Etherington, Sinisa Savic, Michael F. McDermott, and Daniel Peckham. "Anti-inflammatory Effects of Elexacaftor/tezacaftor/ivacaftor in Adults with Cystic Fibrosis Heterozygous for F508del." PLoS ONE 19, no. 5 (2024): 1. https://doi.org/10.1371/journal.pone.0304555.

MLA (9th ed.) Citation

Jarosz-Griffiths, Heledd H., et al. "Anti-inflammatory Effects of Elexacaftor/tezacaftor/ivacaftor in Adults with Cystic Fibrosis Heterozygous for F508del." PLoS ONE, vol. 19, no. 5, 2024, p. 1, https://doi.org/10.1371/journal.pone.0304555.